Literature DB >> 7827153

Pathogenesis of HIV-related Kaposi's sarcoma.

S A Miles1.   

Abstract

Infection with HIV-1 is associated with a 7000-fold increase in the incidence of Kaposi's sarcoma (KS). Some studies suggest that the risk of KS in HIV infection is increased with certain sexual practices and that a sexually transmitted agent could be involved. Exposure to this agent apparently alters both the morphology and growth regulation of the KS progenitor cells. These changes include the expression of the different cytokine receptors and the acquisition of autocrine growth loops. Perturbations of multiple cytokines during HIV infection, including oncostatin-M, interleukin-1 beta, and tumor necrosis factor-alpha, alter the subsequent growth of KS. These studies suggest that control of cytokine perturbations or the underlying HIV-1 infection could result in a significant reduction in the growth rate of AIDS-related KS.

Entities:  

Mesh:

Year:  1994        PMID: 7827153     DOI: 10.1097/00001622-199409000-00009

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  10 in total

Review 1.  Kaposi's sarcoma and its associated herpesvirus.

Authors:  Enrique A Mesri; Ethel Cesarman; Chris Boshoff
Journal:  Nat Rev Cancer       Date:  2010-10       Impact factor: 60.716

2.  Interleukin-4 receptor expression on AIDS-associated Kaposi's sarcoma cells and their targeting by a chimeric protein comprised of circularly permuted interleukin-4 and Pseudomonas exotoxin.

Authors:  S R Husain; P Gill; R J Kreitman; I Pastan; R K Puri
Journal:  Mol Med       Date:  1997-05       Impact factor: 6.354

3.  Strain variability among Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genomes: evidence that a large cohort of United States AIDS patients may have been infected by a single common isolate.

Authors:  J C Zong; C Metroka; M S Reitz; J Nicholas; G S Hayward
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 4.  Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

Authors:  D R Lucey; M Clerici; G M Shearer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

Review 5.  Charting a new course through the chaos of KS (Kaposi's sarcoma)

Authors:  B J Nickoloff; K E Foreman
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

6.  An HIV-negative penil Kaposi's sarcoma.

Authors:  A Demir; Y Temiz; S U Bozkurt; I Erbarut; Y Ilker
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

7.  Identification of two homologs of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in retroperitoneal fibromatosis of different macaque species.

Authors:  T M Rose; K B Strand; E R Schultz; G Schaefer; G W Rankin; M E Thouless; C C Tsai; M L Bosch
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

8.  Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells.

Authors:  Z Y Liu; R K Ganju; J F Wang; M A Ona; W C Hatch; T Zheng; S Avraham; P Gill; J E Groopman
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

9.  Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells.

Authors:  R K Ganju; N Munshi; B C Nair; Z Y Liu; P Gill; J E Groopman
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Implications for oxidative and nitrative stress in the pathogenesis of AIDS-related Kaposi's sarcoma.

Authors:  Susan R Mallery; Ping Pei; David J Landwehr; Christopher M Clark; Jennifer E Bradburn; Gregory M Ness; Fredika M Robertson
Journal:  Carcinogenesis       Date:  2003-12-04       Impact factor: 4.944

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.